Infinity Pharmaceuticals Cash End of Year Trend

Infinity Pharmaceuticals Inc -- USA Stock  

USD 1.83  0.01  0.55%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 18.7 M or Interest Expense of 5.8 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 9.9897 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Cash End of Year of Infinity Pharmaceuticals Inc with missing and latest data points interpolated.
Cash End of Year  10 Years Trend  
Slightly volatile
 Cash End of Year 

Infinity Pharmaceuticals Cash End of Year Over Time

2015-12-31  188,170,000 
2016-12-31  188,170,000 
2017-12-31  260,828,947 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  109,352,928
Geometric Mean  60,557,037
Coefficient Of Variation  98.64
Mean Deviation  95,591,884
Median  68,114,000
Standard Deviation  107,867,355
Range  291,117,771
R Value  0.82
R Squared  0.68
Significance  0.00098053
Slope  24,652,962

Currently Trending

Purchased few shares of
1 hour ago ago
Traded for 1040.48
Purchased over 200 shares of
1 hour ago ago
Traded for 12.6
Purchased over 100 shares of
1 hour ago ago
Traded for 21.65